Shandong Xinhua (China) Today

000756 Stock   15.70  0.82  4.96%   

Performance

4 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 10

 
High
 
Low
Low
Shandong Xinhua is trading at 15.70 as of the 25th of November 2024, a 4.96 percent decrease since the beginning of the trading day. The stock's open price was 16.52. Shandong Xinhua has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Shandong Xinhua Pharmaceutical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of June 2023 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Shandong Xinhua is entity of China. It is traded as Stock on SHE exchange. The company has 487.41 M outstanding shares. More on Shandong Xinhua Pharmaceutical

Moving together with Shandong Stock

  0.79200468 Nanjing Putian TelecPairCorr
  0.82600322 Tianjin Realty DevelPairCorr
  0.83000692 Shenyang Huitian ThermalPairCorr
  0.77300013 Jiangsu Xinning ModernPairCorr

Shandong Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shandong Xinhua's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shandong Xinhua or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman GMTongqing He
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors)
Shandong Xinhua's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Shandong Xinhua's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Shandong Xinhua can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shandong Xinhua's financial leverage. It provides some insight into what part of Shandong Xinhua's total assets is financed by creditors.
Liquidity
Shandong Xinhua cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Shandong Xinhua Pharmaceutical has accumulated 283.96 M in total debt. Debt can assist Shandong Xinhua until it has trouble settling it off, either with new capital or with free cash flow. So, Shandong Xinhua's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Shandong Xinhua Phar sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Shandong to invest in growth at high rates of return. When we think about Shandong Xinhua's use of debt, we should always consider it together with cash and equity.

Change To Inventory

(126.91 Million)
Shandong Xinhua Pharmaceutical (000756) is traded on Shenzhen Stock Exchange in China and employs 7,104 people. Shandong Xinhua is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.72 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shandong Xinhua's market, we take the total number of its shares issued and multiply it by Shandong Xinhua's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shandong Xinhua Phar operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 487.41 M outstanding shares. Shandong Xinhua generates positive cash flow from operations, but has no cash available
Check Shandong Xinhua Probability Of Bankruptcy
Ownership Allocation
Shandong Xinhua Phar shows a total of 487.41 Million outstanding shares. Shandong Xinhua Phar maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shandong Ownership Details

Shandong Xinhua Phar Risk Profiles

Although Shandong Xinhua's alpha and beta are two of the key measurements used to evaluate Shandong Xinhua's performance over the market, the standard measures of volatility play an important role as well.

Shandong Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Shandong Xinhua without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stocks Directory Now

   

Stocks Directory

Find actively traded stocks across global markets
All  Next Launch Module

Shandong Xinhua Corporate Management

Elected by the shareholders, the Shandong Xinhua's board of directors comprises two types of representatives: Shandong Xinhua inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Xinhua's management team and ensure that shareholders' interests are well served. Shandong Xinhua's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Xinhua's outside directors are responsible for providing unbiased perspectives on the board's policies.
Deqing DuDeputy MangProfile
Changqiu CaoCompany SecretaryProfile
Zhonghui ZhengDeputy ManagerProfile
Xiaohong HeChief DepartmentProfile
Zuxing KouDeputy ManagerProfile

Other Information on Investing in Shandong Stock

Shandong Xinhua financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Xinhua security.